Johnson & Johnson Needs To Step Up Its Game

October 15, 2015   |   October 2015 Bond Updates
We believe that J&J may just manage to get back to double digit growth in pharma segment in 6 months time. However, the outlook for its medical devices business continues to be grim in terms of growth, unless the company can meaningfully accelerate its growth in Asia Pacific and other emerging economies. We are currently in the process of reviewing our price estimate for J&J in the light of third quarter results, and will have an update ready soon.

View more at: http://www.forbes.com/sites/greatspeculations/2015/10/14/johnson-johnson-needs-to-step-up-its-game/
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/